Prior infection with the novel coronavirus provides protection against reinfection, according to a new study in hamsters which showed that treatment with convalescent serum limits virus replication in their lungs.
Researchers, including Yoshihiro Kawaoka from the University of Wisconsin-Madison in the US, demonstrated that both low and high doses of the novel corovirus, SARS-COV-2 replicate well in the airways of juvenile as well as adult hamsters.
"SARS-CoV-2-infected hamsters mounted neutralising antibody responses and were protected against rechallenge with SARS-CoV-2," the study, published in the journal PNAS, noted.
They said the virus can also infect both the upper and lower respiratory